LANREOTIDE ACETATE
NDC 69097-907, LANREOTIDE ACETATE, injection, from Cipla USA Inc..
- Product NDC
- 69097-907
- Status
- Listed
- Labeler
- Cipla USA Inc.
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA217193
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69097-907 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LANREOTIDE ACETATE60 mg/.2mL
Pharmacologic classes
Somatostatin Analog [EPC]; Somatostatin Receptor Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69097-907-67 | 69097090767 | 1 POUCH in 1 CARTON (69097-907-67) / 1 SYRINGE in 1 POUCH / .2 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/2892b4c3-0329-4d29-97ff-3b45283bbab1
Use it
Look up 69097-907 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69097-907 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69097-907. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.